News
![rhythm_AI](https://pharmaphorum.com/wp-content/uploads/2020/10/rhythm_AI.png)
RHYTHM AI cleared for large trial of atrial fibrillation map...
UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need